Physician

Ahmed Kamel Abou Hussein, M.D.

According to 2025 Medicare claims, Ahmed Hussein, M.D. (NPI: 1841502275) practices hematology/oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CMC DEPARTMENT OF MEDICINE GROUP PA (NPI: 1588796882; TIN: 223266219) and primary practice location at 08043-4637. Hussein is affiliated with the AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Hussein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 260 traditional Medicare patients, billed 447 HCPCS/CPT codes, and received $32,367 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 750 prescription claims across 225 beneficiaries totaling $800,130 in drug costs, led by Verzenio (Abemaciclib). 2016 DME data shows 12 claims. Open Payments data shows 31 records totaling $132,854. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $10,878 to $32,367. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $247,723 to $800,130. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	61	128	$10,878
2016	165	9,859	$165,947
2017	153	3,089	$66,834
2018	258	528	$41,479
2019	273	556	$46,543
2020	240	479	$43,610
2021	306	583	$54,114
2022	316	515	$44,011
2023	290	525	$42,416
2024	260	447	$32,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	122	$247,723
2016	25	110	$193,685
2017	59	156	$193,820
2018	83	280	$98,330
2019	136	541	$250,995
2020	199	701	$737,057
2021	225	749	$1,066,598
2022	217	784	$767,545
2023	245	909	$1,146,204
2024	225	750	$800,130

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	17	$20
2016	N/R	12	$12
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	41	41	$143
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	24	30	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	152	212	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	69	83	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	24	37	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	25	700	$374,473
Ibrance	Palbociclib	12	336	$185,413
Eliquis	Apixaban	50	1,710	$33,257
Xarelto	Rivaroxaban	15	750	$13,958
Exemestane	Exemestane	49	4,085	$8,729

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$10,522	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$122,332	Cooper University Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Kamel Abou Hussein, M.D.?

Tedicare shows public-source Medicare data for Ahmed Kamel Abou Hussein, M.D. (NPI 1841502275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Kamel Abou Hussein, M.D. have ACO affiliation data?

Ahmed Kamel Abou Hussein, M.D. is shown with ACO affiliation data for AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Ahmed Kamel Abou Hussein, M.D.?

Ahmed Kamel Abou Hussein, M.D. is linked to CMC DEPARTMENT OF MEDICINE GROUP PA (billing NPI 1588796882) in the available physician profile data.

Does Ahmed Kamel Abou Hussein, M.D. have Open Payments data?

Ahmed Kamel Abou Hussein, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.